Literature DB >> 7616053

Endogenous antigen presentation by MHC class II molecules.

A J Sant1.   

Abstract

T cell recognition of antigen requires that a complex form between peptides derived from the protein antigen and cell surface glycoproteins encoded by genes within the major histocompatibility complex (MHC). MHC class II molecules present both extracellular (exogenous) and internally synthesized (endogenous) antigens to the CD4 T cells subset of lymphocytes. The mechanisms of endogenous antigen presentation are the subject of this review. Isolation and amino acid sequencing of peptides bound to the class II molecule indicate that a very high proportion (70-90%) of the total peptides presented by the class II molecule are in fact derived from the pool of proteins that are synthetized within the antigen-presenting cell (APC). This type of sequence information as well as the study of model antigens has indicated that proteins expressed in a diversity of intracellular sites, including the cell surface, endoplasmic reticulum and cytosol can gain access to the class II molecule, albeit with different efficiencies. The main questions that remain to be answered are the intracellular trafficking patterns that allow colocalization of internally synthesized antigens with the class II molecule, the site(s) within the cell where peptide:class II molecule complex formation can take place and whether presentation of 'foreign' as well as 'self' antigens takes place by mechanisms that vary from one cell type to another or that vary with the metabolic state of the APC. If such variability exists, is would imply that the array of peptides displayed by class II molecules at the cell surface has similar variability, a possibility that would impact on self tolerance and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7616053     DOI: 10.1007/BF02935617

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  84 in total

1.  Irreversible association of peptides with class II MHC molecules in living cells.

Authors:  A Lanzavecchia; P A Reid; C Watts
Journal:  Nature       Date:  1992-05-21       Impact factor: 49.962

2.  Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens.

Authors:  E K Bikoff
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

3.  Sequence analysis of peptides bound to MHC class II molecules.

Authors:  A Rudensky; P Preston-Hurlburt; S C Hong; A Barlow; C A Janeway
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

4.  A role for peptide in determining MHC class II structure.

Authors:  S Sadegh-Nasseri; R N Germain
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

5.  MHC class II-restricted presentation of intracellular antigen.

Authors:  S Weiss; B Bogen
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

6.  Autologous peptides constitutively occupy the antigen binding site on Ia.

Authors:  S Buus; A Sette; S M Colon; H M Grey
Journal:  Science       Date:  1988-11-18       Impact factor: 47.728

7.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

8.  Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules.

Authors:  C V Harding; R W Roof; P M Allen; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

Review 9.  Autophagy and other vacuolar protein degradation mechanisms.

Authors:  P O Seglen; P Bohley
Journal:  Experientia       Date:  1992-02-15

10.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  11 in total

1.  Recipient B cells are not required for graft-versus-host disease induction.

Authors:  Catherine Matte-Martone; Xiajian Wang; Britt Anderson; Dhanpat Jain; Anthony J Demetris; Jennifer McNiff; Mark J Shlomchik; Warren D Shlomchik
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-23       Impact factor: 5.742

Review 2.  Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Authors:  Jason M Weaver; Andrea J Sant
Journal:  Immunol Res       Date:  2009-02-07       Impact factor: 2.829

3.  The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection.

Authors:  Francisco A Chaves; Alvin H Lee; Jennifer L Nayak; Katherine A Richards; Andrea J Sant
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

4.  Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation.

Authors:  Joseph D Comber; Tara M Robinson; Nicholas A Siciliano; Adam E Snook; Laurence C Eisenlohr
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

5.  Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.

Authors:  J F Katz; C Stebbins; E Appella; A J Sant
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

6.  Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.

Authors:  Katherine A Richards; Francisco A Chaves; Andrea J Sant
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

Review 7.  Innate and adaptive immune responses toward nanomedicines.

Authors:  Iara Maíra de Oliveira Viana; Sabrina Roussel; Joan Defrêne; Eliana Martins Lima; Frédéric Barabé; Nicolas Bertrand
Journal:  Acta Pharm Sin B       Date:  2021-03-13       Impact factor: 11.413

8.  Urothelial antigen-specific CD4+ T cells function as direct effector cells and induce bladder autoimmune inflammation independent of CD8+ T cells.

Authors:  W Liu; X Chen; D P Evanoff; Y Luo
Journal:  Mucosal Immunol       Date:  2011-01-26       Impact factor: 7.313

Review 9.  The role of major histocompatibility complex molecules in luteal function.

Authors:  Matthew J Cannon; Joy L Pate
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

10.  A modified human ELISPOT assay to detect specific responses to primary tumor cell targets.

Authors:  Anatoli Malyguine; Susan L Strobl; Kimberly A Shafer-Weaver; Tracy Ulderich; Angela Troke; Michael Baseler; Larry W Kwak; Sattva S Neelapu
Journal:  J Transl Med       Date:  2004-03-29       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.